More than a year before the Federal Government announced its compounding ban, the pharmaceutical giant Novo Nordisk was making complaints to AHPRA about pharmacies compounding…
The TGA is banning pharmacists from compounding semaglutide and other GLP-1 receptor agonists, starting 1 October. About 20,000 patients are currently using compounded semaglutide for…
Telehealth corporate Eucalyptus is making headlines for prescribing off-label compounded semaglutide as part of an online weight loss program that costs up to $599 a…
A doctor is warning GPs to be careful when prescribing compounded semaglutide, saying both she and her prescribing doctor appear to have been taken in…
The social media frenzy around semaglutide may have contributed to dozens of overdoses, says a leading endocrinologist, with poisons information centres seeing a spike in…
Adding semaglutide to standard care cuts the risk of fatal and non-fatal cardiac events by 20% in adults with pre-existing cardiovascular disease but not diabetes,…
Semaglutide may be a new therapeutic option for obesity-related heart failure with preserved ejection fraction, with results from a landmark study showing substantial reductions in…
Novo Nordisk has applied for PBS funding for its subcutaneous weight loss drug Wegovy as a severe obesity treatment. The product contains the GLP-1 receptor…
Australian of the Year and leading body image advocate Taryn Brumfitt has claimed that GPs risk turning patients off seeking care by raising their weight…
Body mass index has long been used by doctors as the standard method for measuring health — and often still is. But earlier this month,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
